This promotes optimal body function
How the GLP-1 and GIP Receptor Interaction Works Together The GLP-1 and GIP receptors share overlapping but non-identical intracellular signalling pathways, and their co-activation produces additive and in some research models, synergistic effects on insulin secretion and appetite suppression
Reduced Food Intake: The combination of GIP and GLP-1 activation appears to have synergistic effects on appetite suppression, leading to greater reduction in calorie intake
Hibuse T, Maeda N, Kishida K, Kimura T, Minami T, Takeshita E, Hirata A, Nakagawa Y, Kashine S, Oka A, Hayashi M, Nishizawa H, Funahashi T, Shimomura I
Common adverse effects of Wegovy include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (affecting 2050% of users, particularly during dose escalation) Dehydration risk secondary to gastrointestinal effects Dizziness and fatigue especially when combined with caloric restriction Hypoglycaemia primarily a risk when combined with insulin or sulfonylurea therapy
Breaking through a 10mg weight loss plateau Plateaus happen